OSR RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHSun, 03 May 2026 22:25:10 +0200https://images.finanzen.net/images/finanzen_net_neu.gifOSR RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netOSR zog Bilanz zum jüngsten JahresviertelThu, 02 Apr 2026 06:35:06 +0200https://www.finanzen.net/nachricht/aktien/osr-zog-bilanz-zum-juengsten-jahresviertel-15591026OSR hat am 31.03.2026 die Geschäftsergebnisse zum am 31.12.2025 abgelaufenen Quartal offengelegt.Das EPS wurde auf einen Verlust von 0,16 USD je Aktie beziffert. Im Vorjahresviertel waren -0,460 USD je Aktie erzielt worden.Das ...

]]>https://www.finanzen.net/nachricht/aktien/osr-zog-bilanz-zum-juengsten-jahresviertel-15591026Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in MilestonesMon, 12 Jan 2026 14:05:00 +0100https://www.finanzen.net/nachricht/aktien/vaximm-an-osr-company-receives-binding-term-sheet-from-bcm-europe-for-global-exclusive-license-of-vxm01-with-30m-upfront-and-up-to-815m-in-milestones-15409078

BELLVUE, Wash., Jan. 12, 2026 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH) today announced that its ...

]]>https://www.finanzen.net/nachricht/aktien/vaximm-an-osr-company-receives-binding-term-sheet-from-bcm-europe-for-global-exclusive-license-of-vxm01-with-30m-upfront-and-up-to-815m-in-milestones-15409078Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR HoldingsFri, 19 Dec 2025 17:50:00 +0100https://www.finanzen.net/nachricht/aktien/woori-io-shareholders-approve-share-exchange-to-become-wholly-owned-subsidiary-of-osr-holdings-15371867

Company advancing dual clinical pathways, including a Samsung-supported PoC trial in Korea and a planned U.S. FDA trial with a leading California research university

]]>https://www.finanzen.net/nachricht/aktien/woori-io-shareholders-approve-share-exchange-to-become-wholly-owned-subsidiary-of-osr-holdings-15371867Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three MonthsTue, 02 Dec 2025 15:53:00 +0100https://www.finanzen.net/nachricht/aktien/vaximm-ag-an-osr-company-updates-term-sheet-with-bcm-europe-to-shorten-exclusivity-period-to-three-months-15328646

BELLEVUE, Wash., Dec. 2, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH) today provided an update ...

]]>https://www.finanzen.net/nachricht/aktien/vaximm-ag-an-osr-company-updates-term-sheet-with-bcm-europe-to-shorten-exclusivity-period-to-three-months-15328646OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025Mon, 01 Dec 2025 21:01:00 +0100https://www.finanzen.net/nachricht/aktien/osr-holdings-to-present-at-the-emerging-growth-conference-on-december-10-2025-15326312

BELLEVUE, Wash., Dec. 1, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company ...

]]>https://www.finanzen.net/nachricht/aktien/osr-holdings-to-present-at-the-emerging-growth-conference-on-december-10-2025-15326312Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in MilestonesFri, 21 Nov 2025 15:20:00 +0100https://www.finanzen.net/nachricht/aktien/vaximm-ag-an-osr-company-enters-term-sheet-with-bcm-europe-for-potential-vxm01-license-with-20m-upfront-and-up-to-815m-in-milestones-15304484

BELLEVUE, Wash., Nov. 21, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), today announced that ...

]]>https://www.finanzen.net/nachricht/aktien/vaximm-ag-an-osr-company-enters-term-sheet-with-bcm-europe-for-potential-vxm01-license-with-20m-upfront-and-up-to-815m-in-milestones-15304484OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology ExpansionFri, 14 Nov 2025 17:10:00 +0100https://www.finanzen.net/nachricht/aktien/osr-holdings-appoints-scientific-co-founder-dr-andreas-niethammer-as-chief-executive-officer-of-vaximm-ag-to-lead-next-phase-of-immuno-oncology-expansion-15277263

BELLEVUE, Wash., Nov. 14, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH) today announced the appointment ...

]]>https://www.finanzen.net/nachricht/aktien/osr-holdings-appoints-scientific-co-founder-dr-andreas-niethammer-as-chief-executive-officer-of-vaximm-ag-to-lead-next-phase-of-immuno-oncology-expansion-15277263OSR verkündete Quartalsergebnis zum jüngsten JahresviertelFri, 14 Nov 2025 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/osr-verkuendete-quartalsergebnis-zum-juengsten-jahresviertel-15275353OSR lud am 12.11.2025 zur Finanzkonferenz und hat dort die Zahlen zum am 30.09.2025 abgelaufenen Jahresviertel präsentiert.Der Verlust je Aktie belief sich auf 0,10 USD. Im Vorjahresquartal hatten -0,060 USD je Aktie in ...

]]>https://www.finanzen.net/nachricht/aktien/osr-verkuendete-quartalsergebnis-zum-juengsten-jahresviertel-15275353OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot StudyThu, 06 Nov 2025 14:30:00 +0100https://www.finanzen.net/nachricht/aktien/osr-holdings-announces-woori-io-s-noninvasive-glucose-monitor-demonstrates-high-accuracy-and-precision-in-company-sponsored-pilot-study-15207850

BELLEVUE, Wash., Nov. 6, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH) today announced the key ...

]]>https://www.finanzen.net/nachricht/aktien/osr-holdings-announces-woori-io-s-noninvasive-glucose-monitor-demonstrates-high-accuracy-and-precision-in-company-sponsored-pilot-study-15207850